Background/aim: To describe real clinical outcomes in patients with non-small cell lung cancer who have uncommon epidermal growth factor receptor (EGFR) mutations.
Materials And Methods: We performed a retrospective chart review from 15 medical institutes that cover a population of three million people from April 2008 to March 2019.
Results: There were 102 patients with uncommon EGFR mutation.